|
1
|
International Agency for Research on
Cancer (IARC): Global Cancer Observatory: Cancer Today. Lyon,
France: IARC. Available from: https://gco.iarc.who.int/today. Accessed September 6,
2025.
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Plowman JN, Matoy EJ, Uppala LV, Draves
SB, Watson CJ, Sefranek BA, Stacey ML, Anderson SP, Belshan MA,
Blue EE, et al: Targeted sequencing for hereditary breast and
ovarian cancer in BRCA1/2-negative families reveals complex genetic
architecture and phenocopies. HGG Adv. 5(100306)2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Patel MM and Adrada BE: Hereditary breast
cancer: BRCA mutations and beyond. Radiol Clin North Am.
62:627–642. 2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pal M, Das D and Pandey M: Understanding
genetic variations associated with familial breast cancer. World J
Surg Oncol. 22(271)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Reiner AS, Watt GP, Malone KE, Lynch CF,
John EM, Knight JA, Woods M, Liang X, Tischkowitz M, Conti DV, et
al: Breast cancer susceptibility gene sequence variations and
development of contralateral breast cancer. JAMA Netw Open.
7(e2452158)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Krepischi AC, Achatz MIW, Santos EM, Costa
SS, Lisboa BC, Brentani H, Santos TM, Gonçalves A, Nóbrega AF,
Pearson PL, et al: Germline DNA copy number variation in familial
and early-onset breast cancer. Breast Cancer Res.
14(R24)2012.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Dennis J, Tyrer JP, Walker LC, Michailidou
K, Dorling L, Bolla MK, Wang Q, Ahearn TU, Andrulis IL,
Anton-Culver H, et al: Rare germline copy number variants (CNVs)
and breast cancer risk. Commun Biol. 5(65)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hernández-Gómez C, Hernández-Lemus E and
Espinal-Enríquez J: The role of copy number variants in gene
co-expression patterns for luminal B breast tumors. Front Genet.
13(806607)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pylkäs K, Vuorela M, Otsukka M,
Kallioniemi A, Jukkola-Vuorinen A and Winqvist R: Rare copy number
variants observed in hereditary breast cancer cases disrupt genes
in estrogen signaling and TP53 tumor suppression network. PLoS
Genet. 8(e1002734)2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kumpula TA, Vorimo S, Mattila TT, O'Gorman
L, Astuti G, Tervasmäki A, Koivuluoma S, Mattila TM, Grip M,
Winqvist R, et al: Exome sequencing identified rare recurrent copy
number variants and hereditary breast cancer susceptibility. PLoS
Genet. 19(e1010889)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zavala VA, Serrano-Gomez SJ, Dutil J and
Fejerman L: Genetic epidemiology of breast cancer in Latin America.
Genes (Basel). 10(153)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Larios-Serrato V, Martínez-Ezquerro JD,
Valdez-Salazar HA, Torres J, Camorlinga-Ponce M, Piña-Sánchez P and
Ruiz-Tachiquín ME: Copy number alterations and
epithelial-mesenchymal transition genes in diffuse and intestinal
gastric cancers in Mexican patients. Mol Med Rep.
25(191)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Utrera-Barillas D, Valdez-Salazar HA,
Gómez-Rangel D, Alvarado-Cabrero I, Aguilera P, Gómez-Delgado A and
Ruiz-Tachiquin ME: Is human cytomegalovirus associated with breast
cancer progression? Infect Agent Cancer. 8(12)2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Haraksingh RR, Abyzov A and Urban AE:
Comprehensive performance comparison of high-resolution array
platforms for genome-wide copy number variation (CNV) analysis in
humans. BMC Genomics. 18(321)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang K, Li M, Hadley D, Liu R, Glessner J,
Grant SF, Hakonarson H and Bucan M: PennCNV: An integrated hidden
Markov model designed for high-resolution copy number variation
detection in whole-genome SNP genotyping data. Genome Res.
17:1665–1674. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
McKusick-Nathans Institute of Genetic
Medicine, Johns Hopkins University: Online Mendelian Inheritance in
Man, OMIM®. https://omim.org. Accessed January 2024.
|
|
18
|
Firth HV, Richards SM, Bevan AP, Clayton
S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM and Carter
NP: DECIPHER: Database of chromosomal imbalance and phenotype in
humans using ensembl resources. Am J Hum Genet. 84:524–533.
2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao M, Liu Y, Zheng C and Qu H: dbEMT
2.0: An updated database for epithelial-mesenchymal transition
genes with experimentally verified information and precalculated
regulation information for cancer metastasis. J Genet Genomics.
46:595–597. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gel B and Serra E: karyoploteR: An
R/bioconductor package to plot customizable genomes displaying
arbitrary data. Bioinformatics. 33:3088–3090. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Durinck S, Spellman PT, Birney E and Huber
W: Mapping identifiers for the integration of genomic datasets with
the R/bioconductor package biomaRt. Nat Protoc. 4:1184–1191.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bardou P, Mariette J, Escudié F, Djemiel C
and Klopp C: jvenn: An interactive Venn diagram viewer. BMC
Bioinformatics. 15(293)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Menyhart O, Kothalawala WJ and Győrffy B:
A gene set enrichment analysis for cancer hallmarks. J Pharm Anal.
15(101065)2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fabregat A, Jupe S, Matthews L,
Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger
F, May B, et al: The reactome pathway knowledgebase. Nucleic Acids
Res. 46 (D1):D649–D655. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Szklarczyk D, Kirsch R, Koutrouli M,
Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT,
Pyysalo S, et al: The STRING database in 2023: Protein-protein
association networks and functional enrichment analyses for any
sequenced genome of interest. Nucleic Acids Res. 51 (D1):D638–D646.
2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38 (Web Server Issue):W214–W220. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357(eaan2507)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature. 486:346–352.
2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cancer Genome Atlas Network. Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yu G and He QY: ReactomePA: An
R/bioconductor package for reactome pathway analysis and
visualization. Mol Biosyst. 12:477–479. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wickham H: ggplot2: Elegant graphics for
data analysis. Springer-Verlag, New York, 2016.
|
|
33
|
Derakhshan F and Reis-Filho JS:
Pathogenesis of triple-negative breast cancer. Annu Rev Pathol.
17:181–204. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fernández-Lopez JC, Romero-Córdoba S,
Rebollar-Vega R, Alfaro-Ruiz LA, Jiménez-Morales S, Beltrán-Anaya
F, Arellano-Llamas R, Cedro-Tanda A, Rios-Romero M,
Ramirez-Florencio M, et al: Population and breast cancer patients'
analysis reveals the diversity of genomic variation of the BRCA
genes in the Mexican population. Hum Genomics. 13(3)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Borda V, Loesch DP, Guo B, Laboulaye R,
Veliz-Otani D, French JN, Leal TP, Gogarten SM, Ikpe S, Gouveia MH,
et al: Genetics of Latin American diversity project: Insights into
population genetics and association studies in admixed groups in
the Americas. Cell Genom. 4(100692)2024.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ruíz-Patiño A, Rojas L, Zuluaga J, Arrieta
O, Corrales L, Martín C, Franco S, Raez L, Rolfo C, Sánchez N and
Cardona AF: Genomic ancestry and cancer among Latin Americans. Clin
Transl Oncol. 26:1856–1871. 2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vafaizadeh V, Buechel D, Rubinstein N,
Kalathur RKR, Bazzani L, Saxena M, Valenta T, Hausmann G, Cantù C,
Basler K and Christofori G: The interactions of Bcl9/Bcl9L with
β-catenin and Pygopus promote breast cancer growth, invasion, and
metastasis. Oncogene. 40:6195–6209. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shahrouzi P, Forouz F, Mathelier A,
Kristensen VN and Duijf PHG: Copy number alterations: A
catastrophic orchestration of the breast cancer genome. Trends Mol
Med. 30:750–764. 2024.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Connor AE, Baumgartner RN, Baumgartner KB,
Pinkston CM, John EM, Torres-Mejía G, Hines LM, Giuliano AR, Wolff
RK and Slattery ML: Epidermal growth factor receptor (EGFR)
polymorphisms and breast cancer among Hispanic and non-Hispanic
white women: The breast cancer health disparities study. Int J Mol
Epidemiol Genet. 4:235–249. 2013.PubMed/NCBI
|
|
40
|
Albakova Z, Mangasarova Y, Albakov A and
Gorenkova L: HSP70 and HSP90 in cancer: cytosolic, endoplasmic
reticulum and mitochondrial chaperones of tumorigenesis. Front
Oncol. 12(829520)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Albakova Z: HSP90 multi-functionality in
cancer. Front Immunol. 15(1436973)2024.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shi H, Bevier M, Johansson R,
Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P and Försti A:
Prognostic impact of polymorphisms in the MYBL2 interacting genes
in breast cancer. Breast Cancer Res Treat. 131:1039–1047.
2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Masood D, Ren L, Nguyen C, Brundu FG,
Zheng L, Zhao Y, Jaeger E, Li Y, Cha SW, Halpern A, et al:
Evaluation of somatic copy number variation detection by NGS
technologies and bioinformatics tools on a hyper-diploid cancer
genome. Genome Biol. 25(163)2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chandramohan R, Reuther J, Gandhi I, Voicu
H, Alvarez KR, Plon SE, Lopez-Terrada DH, Fisher KE, Parsons DW and
Roy A: A validation framework for somatic copy number detection in
targeted sequencing panels. J Mol Diagn. 24:760–774.
2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Du R, Dong J, Jiang H, Qi M and Zhao Z:
Comparative study of tools for copy number variation detection
using next-generation sequencing data. Sci Rep.
15(22145)2025.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Oketch DJA, Giulietti M and Piva F: Copy
number variations in pancreatic cancer: From biological
significance to clinical utility. Int J Mol Sci.
25(391)2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hazra A, O'Hara A, Polyak K, Nakhlis F,
Harrison BT, Giordano A, Overmoyer B and Lynce F: Copy number
variation in inflammatory breast cancer. Cells.
12(1086)2023.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yan K, Niu L, Wu B, He C, Deng L, Chen C,
Lan Z, Lin C, Kuang W, Lin H, et al: Copy number variants landscape
of multiple cancers and clinical applications based on NGS gene
panel. Ann Med. 55(2280708)2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Steele CD, Abbasi A, Islam SMA, Bowes AL,
Valber A, Khandekar A, Pickering L, Boyle JM, East P, Pearson A, et
al: Signatures of copy number alterations in human cancer. Nature.
606:984–991. 2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tao Z, Wang S, Wu C, Wu T, Zhao X, Ning W,
Wang G, Wang J, Chen J, Diao K, et al: The repertoire of copy
number alteration signatures in human cancer. Brief Bioinform.
24(bbad053)2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Singh P, Chaturvedi R and Somvanshi P:
Network-based integrative analysis to identify key genes and
corresponding reporter biomolecules for triple-negative breast
cancer. Cancer Med. 14(e70674)2025.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Cheung ATM, Palapattu EL, Pompa IR,
Aldrighetti CM, Niemierko A, Willers H, Huang F, Vapiwala N, Van
Allen E and Kamran SC: Racial and ethnic disparities in a
real-world precision oncology data registry. NPJ Precis Oncol.
7(7)2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Hermawan A and Putri H: Characterizing
excision repair cross-complementing family genes as drug resistance
biomarkers in breast cancer. Beni Suef Univ J Basic Appl Sci.
12(79)2023.
|
|
54
|
Hong L, Tanaka M, Yasui M and Hara-Chikuma
M: HSP90 promotes tumor associated macrophage differentiation
during triple-negative breast cancer progression. Sci Rep.
14(22541)2024.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Gómez-Archila JD, Espinosa-García AM,
Palacios-Reyes C, Trujillo-Cabrera Y, Mejía ALS, González AVA,
Rangel-López E, Alonso-Themann PG, Solís NDS, Hernández-Zavala A,
et al: NOTCH expression variability and relapse of breast cancer in
high-risk groups. Am J Med Sci. 364:583–594. 2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Zito Marino F, Buono S, Montella M,
Giannatiempo R, Messina F, Casaretta G, Arpino G, Vita G,
Fiorentino F, Insabato L, et al: NTRK gene aberrations in
triple-negative breast cancer: Detection challenges using IHC,
FISH, RT-PCR, and NGS. J Pathol Clin Res. 9:367–377.
2023.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Li X, Jin Y and Xue J: Unveiling
Collagen's role in breast cancer: Insights into expression
patterns, functions and clinical implications. Int J Gen Med.
17:1773–1787. 2024.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Dai P, Xiong L, Wei Y, Wei X, Zhou X, Zhao
J and Tang H: A pancancer analysis of the oncogenic role of cyclin
B1 (CCNB1) in human tumors. Sci Rep. 13(16226)2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Su Q, Fang L, Li C, Yue L, Yun Z, Zhang H,
Liu Q, Ma R, Zhong P, Liu H, et al: Multi-omics insights into the
roles of CCNB1, PLK1, and HPSE in breast cancer progression:
Implications for prognosis and immunotherapy. Discov Oncol.
16(471)2025.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Kwon A, Chae HW, Lee WJ, Kim J, Kim YJ,
Ahn J, Oh Y and Kim HS: Insulin-like growth factor binding
protein-3 induces senescence by inhibiting telomerase activity in
MCF-7 breast cancer cells. Sci Rep. 13(8739)2023.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Gronkowska K and Robaszkiewicz A: Genetic
dysregulation of EP300 in cancers in light of cancer epigenome
control-targeting of p300-proficient and -deficient cancers. Mol
Ther Oncol. 32(200871)2024.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Lin F, Huang J, Zhu W, Jiang T, Guo J, Xia
W, Chen M, Guo L, Deng W and Lin H: Prognostic value and immune
landscapes of TERT promoter methylation in triple negative breast
cancer. Front Immunol. 14(1218987)2023.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Yao L, Li Y, Li S, Wang M, Cao H, Xu L and
Xu Y: ARHGAP39 is a prognostic biomarker involved in immune
infiltration in breast cancer. BMC Cancer. 23(440)2023.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Gomez LC, Sottile ML, Guerrero-Gimenez ME,
Zoppino FCM, Redondo AL, Gago FE, Orozco JI, Tello OM, Roqué M,
Nadin SB, et al: TP73 DNA methylation and upregulation of ΔNp73 are
associated with an adverse prognosis in breast cancer. J Clin
Pathol. 71:52–58. 2018.PubMed/NCBI View Article : Google Scholar
|
